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Abstract: Tailored ruthenium sandwich complexes bearing
photoresponsive arene ligands can efficiently promote azide–
thioalkyne cycloaddition (RuAtAC) when irradiated with UV
light. The reactions can be performed in a bioorthogonal
manner in aqueous mixtures containing biological compo-
nents. The strategy can also be applied for the selective
modification of biopolymers, such as DNA or peptides.
Importantly, this ruthenium-based technology and the standard
copper-catalyzed azide–alkyne cycloaddition (CuAAC)
proved to be compatible and mutually orthogonal.
Introduction
Bioorthogonal reactions, by enabling the covalent modi-
fication of specific reactants or biomolecular targets in
complex biological environments, have brought a paradigm
shift on the potential of chemistry for interrogating or/and
altering biology.[1, 2] Within the “toolbox” of bioorthogonal
reactions, those that are catalyzed by transition metals are
especially attractive, owing to their intrinsic metal-dependent
characteristics, and the possibility of tuning the reactivity by
adjusting the characteristics of the catalyst.[3] However,
progress in this field has been slow, in great part because of
the notion that transition metal reagents are incompatible
with aqueous and biological milieu, and that they can be
easily inactivated by biological components. Moreover, while
there has been an increasing number of reports on bioor-
thogonal metal-catalyzed reactions, they usually present low
catalytic efficiencies, especially under the diluted conditions
usually required for biological applications.[3, 4]
Among all transition-metal-mediated bioorthogonal re-
actions, there is one that stands out, namely, the copper(I)-
promoted azide–alkyne cycloaddition (CuAAC).[5,6] The re-
action engages organic azides and alkynes, which are ideal
chemical entities in terms of biological orthogonality, and
tends to exhibit very good rates. However, this transformation
still presents important limitations such as its low compati-
bility with thiols, its restriction to terminal alkynes or the side
reactivity and toxicity of copper (I) ions in biological
contexts.[7] Furthermore, to reach efficient conversions under
typically diluted conditions, the reactive copper(I) species
need to be generated in situ using excess amounts of
a copper(II) source and sodium ascorbate, a reductant which
is not innocent in biological contexts (Figure 1).[8] Therefore,
there is a clear need to discover new, robust and aqueous-
compatible metal-catalyzed annulations as alternatives to the
CuAAC.[9,10]
In this context, in 2017, we reported the first examples of
a ruthenium-catalyzed azide–alkyne cycloaddition that takes
place in aqueous and in biologically relevant milieu.[11] The
method makes key use of thioalkynes as reaction partners,
and of the commercially available complex [Cp*RuCl(COD)]
(Ru1) as catalytic reagent (Figure 1). Following our report,
other groups developed alternative conditions to achieve
Figure 1. Metal-catalyzed azide–(thio)alkyne cycloaddition reactions.
Advantages are marked with blue squares, and limitations with red.
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related cycloadditions in water, using nickel,[12] rhodium[13] or
iridium catalysts,[14] albeit only the latter has been shown to
operate in biological mixtures.
Importantly, all these new metal-catalyzed azide–alkyne
cycloaddition reactions, including our ruthenium-catalyzed
process, have demonstrated effectivity only when the con-
centration of reagents is in the mid to high millimolar range.
This represents an important limitation in terms of developing
biological applications, which usually require very diluted
samples. An additional challenge in this field has to do with
the possibility of controlling the reactivity using external
stimuli, as this could open new opportunities for biological
regulation.
Herein, we demonstrate that cationic RuII complexes such
as [Cp*Ru(MeCN)3]PF6 (Ru2) are excellent precatalysts to
perform efficient, formal cycloadditions between thioalkynes
and azides in aqueous media. Contrary to [Cp*RuCl(COD)]
(Ru1), this cationic complex (Ru2) is very effective under
diluted micromolar conditions, even in PBS and biologically
complex media, such as DMEM, or HeLa cells lysates. More
importantly, we also show that the azide–thioalkyne cyclo-
addition can be catalyzed by [Cp*RuIIarene] sandwich com-
plexes,[15] provided that they are photoactivated by a short-
time irradiation with a LED lamp at 365 nm (Figure 1). The
possibility of controlling the generation of the catalytically
active RuII species with light opens interesting perspectives in
optobiology.[16] Finally, we also demonstrate that this tech-
nology is fully orthogonal with the CuAAC and, moreover, it
can be used for the chemoselective modifications of small
peptides and ssDNAs, for instance, for the introduction of
fluorogenic tags.
Results and Discussion
Our first experiments were carried out with the anthra-
cenyl azide 1a and the thioalkyne 2a, because the resulting
triazole product (3aa) is fluorescent and, thus, the reaction
can be readily monitored. In consonance with previous
observations, the neutral RuII complex [Cp*RuCl(COD)]
(Ru1) was significantly more efficient than [Cp*Ru-
(MeCN)3]PF6 (Ru2), when the reaction was carried out under
anhydrous conditions in CH2Cl2 (75 mM).
[17] Specifically, the
reaction gave a 99% yield of the product after 0.5 h with Ru1
(Table 1, entry 1), but just a 15 % yield with Ru2, after 1 h
(30 % yield after 6 h, entry 2). Several control experiments
and careful analysis by NMR and ESI-MS allowed to discover
that the poorer performance of Ru2 was likely due to the
formation of secondary ruthenium-containing products. In
particular, we could identify Ru2’, which results from an
unprecedented ruthenium-promoted trimerization of thioal-
kynes, a process that generates a chelating dithiofulvene
ligand (Figure 2).[18] The performance of Ru2 in the RuAtAC
could be partially improved using Et3NCl as additive
(5 mol%), probably by favoring the in situ formation of
a neutral Cp*–ruthenium(II) chloride species (entry 3), which
might hamper the thioalkyne-to-fulvene trimerization.[19]
Remarkably, when the reaction catalyzed by Ru2 was
carried out in water, in the presence of this chloride source,
the cycloadduct 3 aa was obtained in 99% yield, after only
0.5 h (entry 4). We later found that the use of Et3NCl is not
needed, as the reaction provided the same yield without any
additive (entry 5). Most likely, the higher activity of Ru2 in
water is partially related to the formation of active RuII aquo
or oxo derivatives, which favor the desired annulation over
alternative pathways.[20] Indeed, we have detected by ESI-MS
several ruthenium-oxygenated species in the aqueous solu-
tions of Ru2.[21]
Importantly, using these conditions, we could promote the
annulation of a variety of azides and thioalkynes (Scheme 1).
Thioalkynes bearing an ethyl group at the sulfur atom were
particularly reactive, but other alkyl groups like benzyl (2c),
isopropyl (2 d) or aromatic substituents (2b) are also toler-
ated, providing in all cases the expected products in good
yields. The other substituent of the thioalkyne can also be
modified without compromising the yields of the desired
triazoles.
Ru2 proved to be much more selective than the previously
described catalyst Ru1 with respect to the type of alkyne
partner used. Indeed, Ru1 promotes the reaction of regular
alkynes lacking the thioether, such as the 2 f and 2g, to give
the corresponding triazoles in moderate to good yields (3 bf,
3bg, Scheme 1). However, the cationic reagent Ru2 failed to
induce any conversion with these alkynes, even after 7 h at rt
Table 1: Viability of the RuAtAC with the RuII cationic complex Ru2.[a]
Entry [Ru] (%) Solvent t [h] Yield [%][b]
1 Ru1 (5) CH2Cl2 0.5 99
2 Ru2 (5) CH2Cl2 1 15 (30)
[c,d]
3[e] Ru2 (5) CH2Cl2 1 28 (72)
[c]
4[e] Ru2 (5) H2O 0.5 99
5 Ru2 (5) H2O 0.5 4
[a] Reaction conditions: 2a (150 mmol), 1a (75 mmol), solvent (1 mL)
and the ruthenium catalyst (5 mol%) were added to a vial under air, and
the mixture stirred for the indicated time. [b] Yield determined by
1H NMR spectroscopy of the reaction crude mixture using 1,3,5-
trimethoxybenzene as an internal standard. [c] The yield after 6 h is
indicated in parenthesis. [d] The complex Ru2’ was detected in the
reaction mixture (NMR and ESI-MS).[18] [e] The Ru complex Ru2 and
Et4NCl (5 mol%) were premixed in the corresponding solvent for 5 min.
Note: Reaction mixtures in water can be considered as suspensions
rather than solutions.
Figure 2. Structure and X-ray crystallographic analysis of Ru2’ (specific
hydrogen atoms and the counterion (PF6
@) are omitted for clarity).
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(Scheme 1). Therefore, Ru2 not only allows to carry out the
annulation in aqueous media in an efficient manner, but also
introduces a level of chemoselectivity that was previously
unattainable with Ru1, allowing to fully distinguish thioal-
kynes from alkynes (both mono- and disubstituted).
Considering this chemoselectivity, we next explored the
orthogonality of the RuAtAC and the CuAAC. When
a mixture of azide 1b (1 equiv.) and alkynes 2a and 2h
(2 equiv. of each one) was treated under standard CuAAC
conditions [that is, CuSO4·5 H2O (5 mol%) and sodium
ascorbate (NaAsc, 10 mol%)] the triazole 3bh, resulting
from the reaction of the terminal alkyne 1h was exclusively
formed in high yield (Table 2, entry 1). If, after this reaction
has been completed (2 h), we add a second equivalent of the
azide, and the catalyst Ru2 (5 mol%), the thioether contain-
ing adduct 3ba is formed in a good 78% yield (entry 2). Even
more relevant, when the initial mixture of the azide 1b and
alkynes 2a and 2h is first treated with Ru2, only the sulfur-
containing triazole 3ba is observed (79% yield, entry 3),
whereas the subsequent addition of 1 a and the Cu catalyst
leads to 3bh in 95% yield (entry 4). Furthermore, when azide
1b was mixed with both 2a and 2h (1 equiv. each) in the
presence of both Cu and Ru catalysts (5 mol% of each one),
an almost equimolar mixture of 3ba and 3bh is obtained, in
an excellent yield (94% yield, entry 5). Overall, these results
confirm a striking chemoselectivity and mutual orthogonality
between both methods and indicate that both cycloadditions
share similar kinetic profiles under these conditions. This
mutual orthogonality promises relevant applications, such as
for the dual tagging of biomolecules.[22]
In view of the excellent performance of Ru2, we explored
its behavior under more diluted conditions. Gratifyingly, the
annulation between 1c and 2 a can be efficiently carried using
azide concentrations of 1 mM (99 % yield), and even at
250 mM, without significant deterioration in the yield (86%
yield).[23]
At this point we questioned the possibility of engineering
ruthenium derivatives that could be activated using external
stimuli, owing to the ensuing possibilities for introducing
temporal control on the activity. Considering that the
precatalyst Ru2 can be made from RuII arene sandwich
complexes of type [Cp*Ru(arene)]X by UV irradiation in
acetonitrile,[15, 24] we anticipated that the catalytic species
resulting from mixing Ru2 with water could be equally
generated from these RuII sandwich complexes, provided that
the arene ligand could be easily released with light under
aqueous conditions. This idea was attractive not only as
a means to control reactivity, but also because of the high
stability of the ruthenium(II) sandwich precursors, which
might be especially useful to avoid its deactivation in
biological contexts.
We therefore synthetized the naphthalene derivative
[Cp*Ru(naphthalene)]BPh4 (Ru3), and two analogs with
pyrene ligands: [Cp*Ru(pyrene)]PF6 (Ru4) and [Cp*Ru(pyr-
ene-SO3Na)]PF6 (Ru5).
[24] Their potential as photoactivatable
catalysts for the RuAtAC was tested in a model reaction using
thioalkyne 2 a and the p-tolyl azide 1b (Table 3).[25] Not
surprisingly, treatment of 1b and 2 a with 5 mol % of Ru3, in
a 9:1 water:CH3CN mixture, did only provide traces of the
triazole product (< 3 % yield, Table 3, entry 1).[23] However,
we were glad to observe that when this mixture was irradiated
with a 365 nm LED lamp for 10 min, the cycloaddition
Scheme 1. Scope of the annulation using the complex Ru2. [a] The
counterion is probably bromide, as in the starting material. [b] Yield of
the reaction carried out using a H2O/DMSO (9:1) mixture is shown in
parenthesis. [c] Carried out using Ru1 instead of Ru2. Fmoc= fluorenyl-
methoxycarbonyl.
Table 2: Orthogonality between RuAtAC and CuAAC annulations.[a]
Entry Catalyst (reaction time) Yield [%][b]
3ba 3bh
1 [Cu] (2 h) 0 78
2[c] [Cu] (2 h); then [Ru] (2 h)[c] 79 78
3 [Ru] (2 h) 79 0
4[c] [Ru] (2 h); then [Cu] (2 h)[c] 78 95
5[d] [Ru] and [Cu] (2 h) 44 50
[a] Reaction conditions: A solution of 2a (2.0 equiv), 2h (2.0 equiv), 1b
(1.0 equiv; 0.75 mmolg@1) in DMSO was added to water (500 mL,
75 mM), followed by the corresponding catalyst: either [Ru] (corre-
sponds to Ru2, 5 mol%) or [Cu] (corresponds to CuSO4·5H2O, 5 mol%,
NaAsc, 10 mol%), in a vial open to air. [b] Yield determined by 1H NMR
spectroscopy using 1,3,5-trimethoxybenzene as an internal standard.
[c] After 2 h, a second equivalent of 1b was added, followed by the
second catalyst. [d] Both [Ru] and [Cu] were present from the beginning.
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proceeded smoothly to afford the desired triazole 3ba in 90%
yield (entry 2). The related pyrene complex Ru4 was slightly
more efficient, providing a 99 % yield upon photoactivation
(10 min/ 365 nm, entry 4). In absence of light there is no
conversion (entry 3). The sulfonate derivative Ru5 also works
under irradiation, although it is less efficient.
With these results in hand, we next studied the behavior of
precatalysts Ru2, Ru4 and Ru5 under more diluted condi-
tions. To carry out these assays we used as substrate the water
soluble triphenylphosphonium-containing azide 1c, because
the phosphonium tag facilitates a highly precise monitoring
by LC–ESI-MS. For comparative purposes, we also analyzed
the performance of our first generation catalyst [Cp*RuCl-
(COD)] (Ru1), which had been poorly effective at the
micromolar range. Reactions were carried out in water, at rt
for 4 h, using different concentrations of the azide 1 c (1 mM,
500 mM, 250 mM and 100 mM) and 50 mol% of the ruthenium
complexes (Figure 3 and Figure S5). In the case of the
photoactivatable complexes Ru4 and Ru5, the reaction
mixture in water, without any cosolvent,[26] was irradiated
for 15 min with a 365 nm LED. Gratifyingly, as can be seen in
the Figure 3, the three ruthenium complexes provided
quantitative yields of the product when using azide concen-
trations of 1 mM and 500 mM (after 4 h), whereas the chloride
ruthenium complex Ru1 provided only a modest 35 % yield
with an azide concentration of 1 mM, or very poor yields at
higher dilutions (2–7% yield). The results at 250 mM showed
that the pyrene RuII complex Ru4 is the most active,
producing a quantitative yield of 3ca, while the analogue
complex bearing a sulfonate moiety (Ru5) led to a moderate
67% yield. The tris(acetonitrile)ruthenium(II) catalyst (Ru2)
and the photoactivatable pyrene complex Ru4 were the most
effective catalysts when the concentration of the azide was
decreased down to 100 mM (30 and 47% yield, respectively).
The amount of Ru2 and Ru4 can be decreased up 15 mol%
without significantly eroding the efficiency (52 and 84 % yield
at 250 mM, respectively with Ru2 and Ru4 ; see Figures S6 and
S7).[27]
As indicated in Scheme 2, the reaction under these diluted
conditions is not limited to 1c and 2a ; other azides and
thioalkynes are also suitable reactants, confirming the poten-
tial of the methodology, either using the precatalyst Ru2 or
the light-activatable precursor Ru4 (Scheme 2).
At this stage, we moved to more demanding, biologically
relevant environments, using a 500 mM concentration of the
azide and 50 mol% of the ruthenium complexes (Figure 4).
Gratifyingly, the cationic complex Ru2 provided very good
results regardless of the biological media used. Thus, yields
above 94 % were obtained in PBS, cell culture milieu
(DMEM), both with and without Fetal Bovine Serum, and
even in presence of HeLa cell lysates. The photoactivatable
complex Ru4 also showed an excellent performance under
Figure 3. Catalyst performance in the micromolar range. Reactions
were conducted in HPLC vials, and yields were determined by UHPLC–
MS using coumarin as an internal standard. Results are the average of
three different reactions. Reaction mixtures in the presence of Ru4 and
Ru5 were irradiated for 15 min at 365 nm to activate the catalyst.
Controls without irradiation for Ru4 and Ru5 provided yields <1%.
Note: The counterion in 1c is Br@ .
Scheme 2. Scope of the reaction at micromolar concentrations (1:
250 mM; 2 : 500 mM). Reactions were conducted in HPLC vials open to
air and yields were determined by UHPLC–MS, using coumarin as an
internal standard. Results are the average of three different reactions.
Reactions using Ru4 were irradiated for 15 min at 365 nm.
Table 3: Viability of the cycloaddition with phototoactivated Cp*Ru
arene complexes Ru3, Ru4 and Ru5.[a]
Entry [Ru] Solvent Conv. [%][b] Yield [%][b]
1 Ru3 H2O/MeCN (9:1) 3 3
2 Ru3 +hn H2O/MeCN (9:1) 90 90
3 Ru4[c] H2O/MeCN (9:1) 1 0
4 Ru4 +hn H2O/MeCN (9:1) 99 99
5 Ru5 +hn H2O/MeCN (9:1) 80 70
[a] Conditions for the reaction under irradiation: 2a (2.0 equiv), 1b
(1.0 equiv), the solvent and [Ru] were sequentially added to a vial, which
was closed and irradiated with a 365 nm LED lamp for 10 min, and the
mixture stirred for 2 h. [b] Yield and conversion determined by 1H NMR
spectroscopy using 1,3,5-trimethoxybenzene as an internal standard.
[c] The reaction was carried out without irradiation.
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light irradiation, providing quantitative yields in PBS as well
as in Hela cell lysates, and good yields, from 59 to 70 %, in cell
culture media. Curiously, Ru5 (with light) performed worse
than Ru4 and Ru2.
To better assess the potential of these catalytic systems, we
compared their performance with that of Rhodium and
Iridium complexes previously developed for related azide–
alkyne annulations.[13,14] Therefore, we tested the reaction of
2a and 1c in water (at 250 mM), as well as in the presence of
cell culture media (at 500 mM), in both cases using 50 mol%
of the metal complexes. Reactions with Rh and Ir complexes
were carried out using the azide:thioalkyne ratio that had
been identified as optimal for each of these metal catalysts
(azide:thioalkyne = 1.5:1 for Ir and 1:2 for Rh).[23] As can be
deduced from Figure 5, [Ir(COD)Cl]2 afforded the desired
product in water in 46% yield, whereas [Rh(CO2)Cl]2 only
provided a 24% yield of 3ca. Unfortunately, the perform-
ances of these metals dropped dramatically when used in
biologically complex media such as DMEM or HeLa Cell
lysates (Figure 5 and Figure S10). Therefore, our ruthenium
complexes are clearly superior in water and, especially under
biologically demanding conditions.
A particularly appealing application of bioorthogonal
chemistry is related with the chemoselective modification of
biopolymers. Therefore, we analyzed whether our catalysts
could also be used for bioconjugation reactions with peptides
or nucleic acids. As indicated in Scheme 3, the trisacetonitrile
RuII complex Ru2 is effective in promoting the cycloaddition
between the thioalkyne 2a and an heptapeptide bearing a 6-
azidolysine at the N-terminal position, to yield the corre-
sponding peptide–triazole in 55 % yield [Scheme 3, Eq. (1)].
More importantly, when this reaction was carried out with the
photoactivatable catalyst Ru4, under 15 min irradiation at
365 nm, the reaction proceeded even more efficiently, provid-
ing the desired peptide conjugate in an excellent 84% yield.
In the case of a ssDNA, we found that oligonucleotides
containing an azide-modified adenine at its 5’ end [Scheme 3,
Eq. (2)], can be readily labelled with a thioalkyne derivative
Figure 4. Reactivity of Ru2, Ru4 and Ru5 under biologically relevant
conditions at 500 mM (1c). Reactions were conducted in HPLC vials.
Reaction yields were measured by UHPLC–MS using an internal
standard (coumarin). Reactions with Ru4 and Ru5 were carried out by
irradiating the mixtures for 15 min at 365 nm to activate the catalyst.
PBS =phosphate buffer solution; DMEM=Dulbecco’s Modified Eagle
Medium; DMEM* =DMEM+ 10% fetal bovine serum+ 1% antibiot-
ics; DEMEM-HEPES =DMEM without phenol red and with HEPES (4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid); Lysates= HeLa cell
lysate 5 mgmL@1.
Figure 5. Comparison of different metal catalysts in the model reac-
tion. In all examples, 50 mol% of the metal complex was used. Ir
stands for [Ir(COD)Cl]2 ; Rh stands for [Rh(CO2)Cl]2. Reactions were
performed using the optimal azide/thioalkyne ratios found for each
metal catalyst (1.5:1 for Ir and 1:2 for Rh and Ru complexes). Yields
were determined by UHPLC–MS using coumarin as an internal
standard.
Scheme 3. DNA and peptide labeling using Ru2 and Ru4 catalysts.
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equipped with a Rhodamine tag, using either Ru2 and Ru4
(with irradiation), to give the expected products in 50 and
72% yields, respectively. Therefore, again, the photoactivat-
able catalyst Ru4 is the one presenting the best performance.
As a final test of the potential of our new catalytic systems,
we checked the viability of the annulations in cellular
environments, using the phosphonium azide 1c. The reaction
could be monitored by LC–MS, owing to the sensitivity
enhancement offered by phosphonium cations in mass
spectrometry (Figure 6).[23] The experiments were carried
out by mixing the ruthenium catalyst (Ru2 or Ru4), the
thioalkyne (2a, 800 mM) and azide 1c (100 mM) in DMEM–
HEPES containing HeLa cells (1 X 106 cellsmL@1). After 2 h,
the cells were centrifuged, the supernatant collected, and the
cell pellets treated with MeOH (80 % aq.) to extract the
cellular content. Both the extracellular media and the
methanol extracts were analyzed by LC–MS. Either using
Ru2, or the photoactivatable complex Ru4 (with irradiation
for 15 min), we were glad to detect the expected reaction
product 3ca, both in the supernatant as well as in the
methanolic extract.[28] Worth to note, the methanolic extract
turned out to be particularly rich in triazole product 3ca,
whereas the supernatant contained considerable amounts of
both azide (1c) and triazole (3ca). However, it is likely that at
least part of the product internalizes after being formed.
Overall, both, the photoactivatable complex Ru4 and the
cationic Ru2, were capable to promote the annulation under
diluted conditions in cellular suspensions.
Conclusion
We have discovered that specifically tailored cationic
ruthenium (II) complexes are highly effective precatalysts to
perform Ruthenium Catalyzed Azide Thioalkyne Cycloaddi-
tions (RuAtAC) in aqueous media. These precatalysts allow
to carry out the annulation under dilute conditions, and also in
complex, biorelevant media.
Moreover, the reaction is fully compatible and mutually
orthogonal to the standard CuAAC. Importantly, the ruthe-
nium reagents can be engineered as arene sandwich com-
plexes to work as light-activatable precatalysts. This provides
not only for the temporal control of the reactivity, but also for
higher efficiencies, likely because of the intrinsic stability of
the metal complexes until receiving the optical stimulus. We
have also demonstrated that the ruthenium complexes can be
used for the orthogonal modification of azide-tagged peptides
and oligonucleotides, and that the reaction can be carried out
in the presence of cells.
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